Methylated DNA Detect in Paraneoplastic Syndrome of Nervous System

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2019

Conditions
Paraneoplastic Neurological Syndrome
Interventions
OTHER

Lung cancer

Paraneoplastic neurological syndrome (PNS) is a clinical syndrome that affects the central nervous system, peripheral nerves, neuromuscular junctions and muscles by the distant influence of the tumor. No tumor cells are visible at the neuropathy site.

OTHER

Suspected lung cancer

Paraneoplastic neurological syndrome (PNS) is a clinical syndrome that affects the central nervous system, peripheral nerves, neuromuscular junctions and muscles by the distant influence of the tumor. No tumor cells are visible at the neuropathy site.

OTHER

Positive methylated DNA

Tumor-free DNA (cfDNA) methylation detection is to determine the cancer condition and cancer type of the subject by detecting the methylation of free DNA released by tumor cells.

Trial Locations (1)

Unknown

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER

NCT04454853 - Methylated DNA Detect in Paraneoplastic Syndrome of Nervous System | Biotech Hunter | Biotech Hunter